Maisonneuve-Rosemont Hospital — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Maisonneuve-Rosemont Hospital appears in 16 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials16

Recruiting shown2

Roles2

SourceClinicalTrials.gov

Clinical trials

16 shown

Single Pre-Operative Radiation Therapy - With Delayed or No Surgery (SPORT-DNS)NCT05217966 · lead sponsor · 2021-10-08

Visual Outcomes of Vivity in Patients With Well Controlled GlaucomaNCT05075226 · lead sponsor · 2021-07-29

Comparison of Perioperative Opioid Consumption Following Pectoral Nerve Block for Breast Cancer SurgeryNCT02741232 · lead sponsor · 2016-03-01

Effect of Laparoscopic Sleeve Gastrectomy in the Morbidly Obese, Kidney Transplant CandidateNCT01913392 · lead sponsor · 2013-07-18

The Impact of Topical Prostaglandins on the Biomechanical Properties of the Cornea in Patients With Open Angle GlaucomaNCT02388360 · lead sponsor · 2013-05-06

Single Pre-Operative Radiation Therapy (SPORT) for Low Risk Breast CancerNCT01717261 · lead sponsor · 2012-08-01

Ginkgo Biloba and Ocular Blood Flow in Primary Open-angle GlaucomaNCT02376114 · lead sponsor · 2011-08-01

Safety Evaluation of Dexmedetomidine for EBUS-TBNANCT01381627 · lead sponsor · 2011-06-01

The DIOXXACT Trial(Diurnal IOP and OBF Xalatan vs Xalatan And Cosopt Trial)NCT00957190 · lead sponsor · 2009-05-04

Trabeculectomy With Mitomycin C Associated With Sub-conjunctival Injection of RanibizumabNCT00892398 · lead sponsor · 2009-03-01

Efficiency of Preoxygenation in Obese Patients: Pressure Assisted Versus Traditional MethodNCT00673634 · lead sponsor · 2008-03-01

The Impact of a Brief Educational Intervention on Glaucoma AdherenceNCT02097979 · lead sponsor · 2007-07-01

Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)NCT05592938 · collaborator · 2023-06-27

Radio-Immuno-Modulation in Lung CancerNCT02579005 · collaborator · 2018-04-20

IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing CABGNCT01033617 · collaborator · 2009-12-01

Periodical Presumptive Treatment for the Control of Gonococcal Infections Among Sex WorkersNCT01329588 · collaborator · 2001-03-01

Drugs studied in this sponsor's trials

4 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Maisonneuve-Rosemont Hospital as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

dexmedetomidine1

Ginkgo biloba extract1

ranibizumab1

remifentanil1

dexmedetomidine RxCUI 48937 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial Ginkgo biloba extract RxCUI 236809 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial ranibizumab RxCUI 595060 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial remifentanil RxCUI 73032 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor12

collaborator4

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.